ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs MXN
17.7793
0.27%
Brent Oil
83.985
-0.42%
Bitcoin
63,781.66
-1.65%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Arcturus Therapeutics Holdings Inc (ARCT)

  7. Arcturus Therapeutics Holdings Inc (ARCT) Noticias

ARCT

Arcturus Therapeutics (ARCT)

Arcturus Therapeutics Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ARCT
FechaHoraFuenteTítuloSímboloCompañía
02/11/202202:45TipRanksArcturus Shoots Up After Strategic Tie-Up With CSL SeqirusNASDAQ:ARCTArcturus Therapeutics Holdings Inc
01/11/202218:27Dow Jones NewsArcturus Up 26% After Hours on CSL Seqirus Vaccine CollaborationNASDAQ:ARCTArcturus Therapeutics Holdings Inc
01/11/202217:05Business WireArcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA VaccinesNASDAQ:ARCTArcturus Therapeutics Holdings Inc
01/11/202217:00PR Newswire (US)CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine TechnologyNASDAQ:ARCTArcturus Therapeutics Holdings Inc
26/10/202215:30Business WireArcturus Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 9, 2022NASDAQ:ARCTArcturus Therapeutics Holdings Inc
27/09/202217:00Business WireArcturus Therapeutics to Attend the Following Investor ConferencesNASDAQ:ARCTArcturus Therapeutics Holdings Inc
01/09/202216:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
31/08/202215:00Business WireArcturus Announces $63.2 Million Award from the U.S. Government to Support Development of Self-amplifying mRNA Vaccine for Rapid Pandemic Influenza ResponseNASDAQ:ARCTArcturus Therapeutics Holdings Inc
18/08/202207:00Business WireArcturus Reports Durability Data Against Omicron Variants, Including BA.5, at Six-Month Timepoint Following Booster with ARCT-154 COVID-19 VaccineNASDAQ:ARCTArcturus Therapeutics Holdings Inc
17/08/202215:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
10/08/202221:46TipRanksArcturus Therapeutics (ARCT) Receives a Hold from Robert W. BairdNASDAQ:ARCTArcturus Therapeutics Holdings Inc
09/08/202215:12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
09/08/202215:00Business WireArcturus Therapeutics Announces Second Quarter 2022 Financial Update and Pipeline ProgressNASDAQ:ARCTArcturus Therapeutics Holdings Inc
01/08/202215:00Business Wire Arcturus Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 9, 2022NASDAQ:ARCTArcturus Therapeutics Holdings Inc
30/06/202215:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
21/06/202219:00Business WireArcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
25/05/202203:40TipRanksArcturus Therapeutics (ARCT) Gets a Sell Rating from Goldman SachsNASDAQ:ARCTArcturus Therapeutics Holdings Inc
13/05/202212:45TipRanksBrookline Capital Markets Thinks Arcturus Therapeutics’ Stock is Going to RecoverNASDAQ:ARCTArcturus Therapeutics Holdings Inc
12/05/202216:01Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
09/05/202215:00Business WireArcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline ProgressNASDAQ:ARCTArcturus Therapeutics Holdings Inc
05/05/202208:02Business WireCORRECTING and REPLACING GRAPHIC Arcturus Reports Strong Three-Month Durability Results from ARCT-154 Booster TrialNASDAQ:ARCTArcturus Therapeutics Holdings Inc
05/05/202207:00Business WireArcturus Reports Strong Three-Month Durability Results from ARCT-154 Booster TrialNASDAQ:ARCTArcturus Therapeutics Holdings Inc
27/04/202207:00Business WireArcturus Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 9, 2022NASDAQ:ARCTArcturus Therapeutics Holdings Inc
20/04/202211:05TipRanksArcturus Therapeutics (ARCT) Receives a Hold from H.C. WainwrightNASDAQ:ARCTArcturus Therapeutics Holdings Inc
20/04/202206:30Business WireArcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 StudyNASDAQ:ARCTArcturus Therapeutics Holdings Inc
11/04/202212:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
25/03/202208:49Business WireArcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease SummitNASDAQ:ARCTArcturus Therapeutics Holdings Inc
14/03/202207:00Business WireArcturus Therapeutics to Participate in the Barclays Global Healthcare ConferenceNASDAQ:ARCTArcturus Therapeutics Holdings Inc
03/03/202204:22TipRanksArcturus Therapeutics (ARCT) Receives a Sell from Robert W. BairdNASDAQ:ARCTArcturus Therapeutics Holdings Inc
01/03/202205:46Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ARCT

Su Consulta Reciente

USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
NASDAQ
MSFT
Microsoft
FX
EURMXN
Euro vs MXN
NYSE
MCD
McDonalds
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
USOTC
BASFY
BASF (QX)
NYSE
AXP
American Express
COIN
BTCUSD
Bitcoin
AMEX
XLV
Health Care Select Sector
CCOM
US30
US 30
NASDAQ
AMZN
Amazon.com
FX
EURUSD
Euro vs US Dollar
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados